Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland

The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in 2010 to the childhood vaccination program in Greenland. This study aimed to estimate the effectiveness of the PCV13 on the incidence of invasive pneumococcal disease (IPD) in children and in adults in Greenland. IPD cases from th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolova, Kristiana Alexandrova, Andersson, Mikael, Slotved, Hans-Christian, Koch, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537731/
https://www.ncbi.nlm.nih.gov/pubmed/34696230
http://dx.doi.org/10.3390/vaccines9101123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537731/
https://www.ncbi.nlm.nih.gov/pubmed/34696230
http://dx.doi.org/10.3390/vaccines9101123

Ejemplares similares